{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:04:30Z","timestamp":1747206270040,"version":"3.40.5"},"reference-count":6,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IDR"],"DOI":"10.2147\/idr.s401620","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T15:40:10Z","timestamp":1672242010000},"page":"7789-7790","source":"Crossref","is-referenced-by-count":0,"title":["A Reply to the Letter in Response to the Article \u201cSeroprevalence of Hepatitis B Virus, Hepatitis C Virus, Syphilis, and Associated Factors Among Female Sex Workers in Gondar Town, Northwest Ethiopia\u201d [Response to Letter]"],"prefix":"10.2147","volume":"Volume 15","author":[{"given":"Mitikie","family":"Wondmagegn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3116-7404","authenticated-orcid":true,"given":"Yitayih","family":"Wondimeneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1608-6737","authenticated-orcid":true,"given":"Alem","family":"Getaneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5810-1117","authenticated-orcid":true,"given":"Getnet","family":"Ayalew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,12]]},"reference":[{"key":"ref1","unstructured":"The European initiative hepatitis C and drug use. Available from: https:\/\/www.hcvcommunitytesting.info\/hepatitis-b-serology\/. Accessed December 21, 2022."},{"key":"ref2","unstructured":"Centres for Diseases control and prevention (CDC). Viral hepatitis (Hepatitis B virus): interpretation of hepatitis B serologic test results-table. Available from: https:\/\/www.cdc.gov\/hepatitis\/hbv\/testingchronic.htm. Accessed December 21, 2022."},{"key":"ref3","unstructured":"Centres for Diseases control and prevention (CDC). Viral hepatitis (Hepatitis C virus): recommended testing sequence for identifying current hepatitis C Virus (HCV) infection. Available from: https:\/\/www.cdc.gov\/hepatitis\/hcv\/guidelinesc.htm. Accessed December 21, 2022."},{"key":"ref4","first-page":"664","volume":"14","author":"Joshi","year":"2014","journal-title":"Ochsner J"},{"key":"ref5","first-page":"5","volume":"2019","author":"Ayalew","year":"2019","journal-title":"Ethiop Med J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1212\/01.CPJ.0000435752.17621.48","volume":"4","author":"Henao-Mart\u00ednez","year":"2014","journal-title":"Neurol Clin Pract"}],"container-title":["Infection and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=86479","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=86479","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T15:40:17Z","timestamp":1672242017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/a-reply-to-the-letter-in-response-to-the-article-ldquoseroprevalence-o-peer-reviewed-fulltext-article-IDR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":6,"URL":"https:\/\/doi.org\/10.2147\/idr.s401620","relation":{},"ISSN":["1178-6973"],"issn-type":[{"type":"electronic","value":"1178-6973"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}